FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileCompumedics Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CMP.AX
Compumedics Limited Stock AnalysisComprehensive stock analysis for Compumedics Limited (CMP.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisCMP.AX
CMP.AX
Compumedics Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
CMP.AX
  1. Home
  2. Stocks
  3. Compumedics Limited

Compumedics Limited

🇦🇺CMP.AX•ASX

Compumedics Limited

🇦🇺CMP.AX•ASX
P/E ratio
218.18

Your view on CMP.AX

P/E
218.18
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Compumedics Limited

Industry
Medical - Devices
Sector
Healthcare
CEO
David Burton
Headquarters
30-40 Flockhart Street, Abbotsford, VIC, AU
Industry
Medical - Devices
Sector
Healthcare
CEO
David Burton
Headquarters
30-40 Flockhart Street, Abbotsford, VIC, AU
Description

Compumedics Limited is a global medical technology enterprise engaged in the full lifecycle of designing, producing, marketing, and distributing advanced diagnostic medical devices. Its market reach extends across Australia, the Asia Pacific region, the Americas, Europe, and the Middle East.

The company's product portfolio is primarily focused on solutions for sleep and neurological disorders.

For sleep diagnostics, offerings include sophisticated PSG:EEG amplification systems like the Grael 4K, portable recording units such as the Somté PSG and Siesta 802, wearable monitoring devices like Somfit/Somfit Pro, and transcutaneous monitors (e.g., TCM5 FLEX). In the field of neurology, Compumedics supplies devices like the ONsight A.V.S.

for home ambulatory studies, a variety of EEG amplifiers (e.g., Grael 4K-EEG, Grael LT EEG), comprehensive long-term EEG monitoring systems (Neuvo 64-512 Channel LTM), and specialized EMG/EP systems (including Xegis Forte and Xegis G:NEO).

Complementing its hardware, the company develops an extensive range of software, featuring the Profusion Sleep and EEG platforms, Profusion neXus 360 (a web-based system for patient data and lab management), a Multi-Modal Neuroimaging Suite, and workflow optimization tools like Profusion neXus Laboratory Management and Scheduler.

Other software offerings include HD Digital Video integration and various specialized applications.

Furthermore, Compumedics provides magnetoencephalography systems, cutting-edge brain research technologies, services for pharmaceutical clinical trials and research, as well as a diverse array of accessories and consumables crucial for diagnostic and research endeavors.

Established in 1987, Compumedics Limited is based in Abbotsford, Australia, and functions as a subsidiary of D & DJ Burton Holdings Pty Ltd.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Compumedics Limited. Starting points for Compumedics Limited: P/E 218.2, beta 0.37 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Compumedics Limited. Compumedics Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Compumedics Limited. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · AUD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent QtrJun 2017Next QtrJun 2022Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimateAUD 0.01AUD 0.02AUD 0.02AUD 0.03
Low estimateAUD 0.01AUD 0.02AUD 0.02AUD 0.03
High estimateAUD 0.01AUD 0.02AUD 0.02AUD 0.03
No. of analysts3211
Year-ago EPS——AUD 0.001—
Growth————

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrJun 2017Next QtrJun 2022Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimateAUD 38.86MAUD 55.32MAUD 75.60MAUD 91.00M
Low estimateAUD 31.82MAUD 42.49MAUD 75.60MAUD 91.00M
High estimateAUD 44.65MAUD 66.50MAUD 75.60MAUD 91.00M
No. of analysts3311
Year-ago revenue——AUD 60.25M—
Growth——+25.5%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Compumedics Limited. Compumedics Limited has reported as a listed company since 2000. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold CMP.AX20 companies
Compare CMP.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
ATX.AXAmplia Therapeutics LimitedHealthcareBiotechnology—
BMT.AXBeamtree Holdings LimitedHealthcareMedical - Healthcare Information Services—
CSX.AXCleanSpace Holdings LimitedHealthcareMedical - Devices—
CYC.AXCyclopharm LimitedHealthcareMedical - Devices—
CYP.AXCynata Therapeutics LimitedHealthcareBiotechnology—
DOC.AXDoctor Care Anywhere Group PLCHealthcareMedical - Healthcare Information Services—
GSS.AXGenetic Signatures LimitedHealthcareMedical - Diagnostics & Research—
IPD.AXImpediMed LimitedHealthcareMedical - Devices—
More Medical - Devices companies
TickerTypeCompanySectorExchangeMkt cap
CBL.AXControl Bionics LimitedHealthcareASX—
CBLLCeriBell, Inc.HealthcareNASDAQ$995.3M
CERSCerus CorporationHealthcareNASDAQ$391.8M
CGHCCapital Group Holdings, Inc.HealthcareOTC$9,220
CHEOFCochlear LimitedHealthcareOTC$8.9B
CHEOYCochlear LimitedHealthcareOTC$9.2B
CHYPFHealth Logic Interactive Inc.HealthcareOTC$165,839
CLLKFBICO Group AB (publ)HealthcareOTC$123.3M
CLPTClearPoint Neuro, Inc.HealthcareNASDAQ$247.1M
CLVSFCellaVision AB (publ)HealthcareOTC$378.0M
CNMDCONMED CorporationHealthcareNYSE$1.4B
CNVIFConavi Medical Corp.HealthcareOTC$20.7M
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Compumedics Limited. Coverage tracks Compumedics Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Compumedics Limited.

CMP.AX AnalysisWeak
Past
1
Growth
3
Health
3
Profit
1
Value
1

News

Latest Market News